REG Investor Presentation 1H FY26

Open PDF
Stock Regis Healthcare Ltd (REG.ASX)
Release Time 23 Feb 2026, 8:44 a.m.
Price Sensitive Yes
 REG Investor Presentation 1H FY26
Key Points
  • Revenue from services up 18.4% to $667.7 million
  • Underlying EBITDA up 3.7% to $70.6 million
  • Net operating cash flow up 39.9% to $291.7 million
Full Summary

Regis Healthcare reported a solid set of results for 1H FY26, with revenue from services increasing 18.4% to $667.7 million, driven by higher average occupancy, AN-ACC and hotelling supplement increases, and contributions from recent acquisitions. Underlying EBITDA grew 3.7% to $70.6 million, while underlying NPAT was up 0.1% to $29.7 million. Net operating cash flow increased 39.9% to $291.7 million, supported by a $178.5 million net RAD cash inflow. The company declared a fully-franked interim dividend of 9.0 cents per share, the first since FY19. Operationally, Regis achieved a mature homes average occupancy of 96.0% and improved its average overall star rating to 3.92. The company completed the acquisitions of Rockpool (4 homes, 600 beds) and OC Health (2 homes, 230 beds) during the period, adding 830 beds to its portfolio. Regis also continued to invest in greenfield developments and refurbishments, with capital expenditure of $102.1 million. Looking ahead, the company remains focused on its growth strategy, with an active M&A pipeline and ongoing investment in its existing portfolio.

Guidance

Regis did not provide any high-importance, price-sensitive forward-looking financial metrics in the announcement.